Patients and healthcare providers in the United States can learn more about QINLOCK® (ripretinib) by visiting the product websites below or by accessing the prescribing information.
Executing on our mission to discover, develop, and deliver important medicines that have meaningful impact on patients.
Patients and healthcare providers in the United States can learn more about ROMVIMZA® (vimseltinib) by visiting the product websites below or by accessing the prescribing information.
Personalized support and financial assistance for eligible U.S. patients receiving QINLOCK® or ROMVIMZA®.
Compliance and State Disclosures
The following are registered trademarks of Deciphera Pharmaceuticals, LLC: QINLOCK, the QINLOCK logo, ROMVIMZA, the ROMVIMZA logo, DECIPHERA, and the Deciphera logo.